Sanofi, GSK to seek authorization
for COVID-19 vaccine
|
|
Late-stage
trials found that two doses of the vaccine were about 58% effective in
preventing infection and 75% effective in preventing moderate to severe
disease, the companies said in a statement. |
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
No comments:
Post a Comment